EMERALD HEALTH SCIENCES INC.
July 11, 2022 07:00 ET
|
Emerald Health Sciences Inc.
EARLY WARNING NEWS RELEASE Vancouver, British Columbia, July 11, 2022 (GLOBE NEWSWIRE) -- Emerald Health Sciences Inc. ("Sciences") announces that on July 8, 2022 pursuant to return of...
Emerald Health Therapeutics Announces Completion of Accordion Provision of Pure Sunfarms’ Credit Facility
July 01, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, July 01, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale,...
Emerald Health Therapeutics’ Joint Venture Pure Sunfarms’ Branded Products Ship to Saskatchewan and are Approved in Manitoba
June 24, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 24, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale,...
Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
June 19, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 19, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and ended March 31,...
Emerald Health Therapeutics Announces Pure Sunfarms’ Initial Cultivation and Sales License for Second Greenhouse
May 25, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its joint venture for large-scale, low-cost,...
Emerald Health Therapeutics Reports Pure Sunfarms First Quarter 2020 Financial Results
May 15, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
Pure Sunfarms achieves fifth consecutive profitable quarter and 179% quarter-to-quarter growth in retail branded product sales volume; builds on retail success in Ontario with 20% market share in...
Emerald Health Therapeutics’ Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M and Completes Additional $8M Financing
April 03, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, April 03, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced that its Pure Sunfarms (“PSF”) joint venture has...
Emerald Health Therapeutics Signs LOI with Sigma Analytical Services
March 09, 2020 07:05 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, March 09, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) has signed a letter of intent under which Sigma...
Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Complete Settlement of All Disputes
March 09, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, March 09, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release dated March...
Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Settle All Disputes
March 03, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, March 03, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has entered into a settlement agreement (the "Settlement...